{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-024422","form_type":"8-K","ticker":"GTBP","cik":"0000109657","company_name":"GT Biopharma, Inc.","filed_at":"2022-08-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.973613+00:00","generated_at":"2026-06-23T19:12:31.968593+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"GT Biopharma settles $6.5M Cytovance debt with stock and cash; aims for IND filings by Mar/Jun 2023","bullets":["Issued 1,222,281 shares to Cytovance to settle $3.25M of invoices; will pay another $3.25M in cash over three months.","Future invoices paid 50% cash and 50% in common stock at closing price; materials invoices all cash.","Cytovance to facilitate GTB-3650 IND by March 31, 2023 and GTB-5550 IND by June 30, 2023, subject to conditions.","Cytovance ownership capped at 4.9% of outstanding; daily resale limited to 50k shares or 1/3 of avg weekly volume.","Parties release each other from claims arising prior to agreement effectiveness."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-024422","json":"https://secwatch.observer/filing/0001493152-22-024422.json","markdown":"https://secwatch.observer/filing/0001493152-22-024422.md","text":"https://secwatch.observer/filing/0001493152-22-024422.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/109657/000149315222024422/0001493152-22-024422-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/109657/000149315222024422/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T19:12:31.968593+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}